Assentia

What Assentia does

Assentia is a privately held, technology-enabled pharmaceutical services company founded in 2022 and headquartered in Raleigh, North Carolina. The firm sits between pure-play SaaS vendors and clinical research organisations (CROs), targeting life-sciences sponsors and CROs that need to operate Clinical Trial Agreements (CTAs), site budgets, and site payment workflows across multi-year studies. Per its firmographic profile, Assentia reports 101–250 employees, indicating it is past the seed/startup phase but still scaling; the company discloses no IPO, funding-round, or revenue data in the available material.

Within Assentia, the operating product line is delivered through Ledger Run, Inc. and its ClinRun platform. ClinRun is positioned as a complete clinical-trial financial-operations system spanning the CTA-to-Pay lifecycle. The platform combines two software modules — a Contracts Module (CTA drafting, negotiation, finalisation and site-budget creation) and a Site Payments Module (management of payments from initial budget through to final disbursement) — with two expert-services lines: Contract Services for in-region CTA creation, budgeting, and negotiation, and Payment Services for global site-payment management and oversight. Marketing material emphasises integration with existing clinical trial systems and interoperability with sites' preferred tools, rather than forcing a closed-stack migration.

The business model is hybrid: enterprise SaaS licences for the Contracts and Site Payments modules paired with fee-based managed services for organisations that prefer outsourced execution. Customer outcomes cited are operational rather than clinical — over $2B in payments processed, 1-day payment processing against a stated 2–3 week industry baseline, and a 20% reduction in invoice processing time. No pricing model, contract structure, customer logos, geographic footprint, or quantified revenue are disclosed in the available data, so specific GTM mechanics (direct sales vs. partner channel, land-and-expand motion, ACVs) cannot be confirmed from the input.

Name

Assentia

Legal name

Ledger Run, Inc.

Website

https://assentiaglobal.com

Company type

Private

Founded year

2022

Operating status

Operating

Headcount range

101–250 employees

Short description

Assentia is a Raleigh-based, technology-enabled pharmaceutical services provider whose Ledger Run / ClinRun platform manages clinical-trial site contracts and payments for life-sciences sponsors and CROs.

Ownership category

akta.pro rank

Headquarters

HQ city

Raleigh

HQ country

United States

HQ region

North America

Markets served

GTM type

B2B

Offering type

Software

Cost components

Personnel, Technology or R&D, Operations, Marketing or Sales

Core offering

Assentia is a technology-enabled pharmaceutical service provider offering ClinRun, a clinical trial management platform that combines software with expert services to manage site contracts and payments for life sciences teams. The platform supports Clinical Trial Agreement (CTA) creation, site budget negotiation, and payment processing workflows, transforming manual trial financial processes into automated workflows from CTA to Pay.

Product overview

Ledger Run delivers ClinRun, a complete clinical trial financial operations platform combining software modules (Contracts, Site Payments) with expert services (Contract Services, Payment Services). The platform transforms manual, slow, and error-prone trial financial processes into fast, transparent, and automated workflows from CTA-to-Pay.

Differentiator

Problem solved

Functional benefit

Brands

• ClinRun: Clinical trial management platform for site contracts and payments, offering CTA creation, budgeting, negotiations, and site payment management.

Products and services

• ClinRun

Ideal customer profiles2 records

Technology focussed Yes

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Recent moves4 records

Expansion highlights4 records

Broad incumbents

• IQVIA: IQVIA combines CRO services with proprietary clinical technology platforms and site-facing capabilities, giving it both the operational scale to deliver site contracts and payments as a service and the technology footprint to displace standalone platforms.
• Medidata Solutions: Medidata (Dassault Systèmes) provides an end-to-end clinical trial platform including CTMS, EDC, and payments-related workflows, competing for the same sponsor technology spend and able to bundle site financial operations into a wider offering.
• Oracle Health Sciences (Clinical One): Oracle Clinical One is a broad clinical trial platform spanning EDC, randomization, and trial management, sitting inside large pharma's system-of-record and able to extend into site payments and contracts.

Emerging players

• Castor: Castor offers a clinical trial data platform (EDC, ePRO, eConsent) used by sponsors and CROs, representing a younger, cloud-native competitor expanding from data capture into broader trial operations workflows that intersect with site payments.

Direct peers

• WCG (WIRB-Copernicus Group): WCG offers site enablement and clinical trial operations services including study startup, site payments, and IRB services, directly competing with Ledger Run's site contract drafting and payment management capabilities.
• Florence Healthcare: Florence's electronic Investigator Site File (eISF) and site collaboration platform streamline document exchange between sponsors, CROs, and sites, competing for similar site-facing workflow budgets and study-startup tooling spend.
• Advarra: Advarra provides site-facing clinical research services and technology across IRB review, study startup, and clinical operations enablement, overlapping with Ledger Run's site contract and payment enablement focus for sponsors and CROs.
• RealTime Software Solutions: RealTime delivers CTMS and site payment solutions purpose-built for research sites and sponsors, with overlapping site contract, budgeting, and payment execution functionality targeted at the same buyer.
• Veeva Systems: Veeva's Vault CTMS and Vault Payments suite address site contract drafting, negotiation, and global site payment execution for life sciences sponsors and CROs — directly competing with Ledger Run's CTA-to-Pay wedge, with far broader enterprise distribution.

Others

• Veeva Vault CDB: Veeva's clinical data and operations suite, while part of Veeva, is separately highlighted because sponsors increasingly evaluate it as an ecosystem against best-of-breed point solutions like Ledger Run for site operations and financial workflows.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/assentia-inc

Revenue estimate

Valuation estimate

Number of profiles

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Assentia